An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally.
VERDICT
The label
Accumulation
read at $137.16
BNY Mellon holds its Accumulation at $137.16.
PHPhase · the trend structure carries the Accumulation label
INInsiders · no filings inside 60 days, left as found
POPositioning · no disclosures inside 60 days, left as found
OPOptions · no verdict drawn today, left as found
SCScreen · does not pass the values gate
edge confirmed
edge broken
edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
INVESTOR
The investor read · the season, not the day
As held on the ledger · 2026-07-19
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 54 days
Price
$137.16
Valuation
17.02 trailing · 14.23 forward price to earnings
Values screen
FAIL· score 10.0
Beta
1.07
OPPORTUNITY
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades at roughly a 5% discount to our $144.57 fair value, moderate competitive moat, 13.40% revenue growth.
Read at
$137.16
17.02 P/E · 14.23 fwd
Our fair value
$144.57
5% discount
Analyst target (avg)
$144.50
+5% to current
Target low $120.00Analyst target rangeTarget high $156.00
▲ current $137.16 · | average target
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Current
$137.16
you are here
Conservative
$108.47
-21%
Analyst avg
$144.50
+5%
Our fair value
$144.57
+5%
Analyst high
$156.00
+14%
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Revenue growth
13.40%
Profit margin
28.72%
Analyst consensus
Buy · 14 covering
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
SCREEN
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
The common standard· AAOIFI Used by most halal investing apps✗ DOES NOT PASS
Our stricter standard· asset-based The one Titan applies✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
Business activityBusiness activity: Financials sectorFail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
PLAIN
The business, in plain words · what the numbers mean
Trusted Custodian Bank Still Fails Our Screen
Picture a quiet back office moving trillions in assets for pension funds and asset managers every day. BNY Mellon sits at the centre of that plumbing yet we pass because it fails the business activity screen outright. The ethical red flag overrides everything else on the table.
Revenue is growing 13 percent with a 29 percent profit margin and 13 percent return on equity at a forward multiple of 14.2 times. Our fair value sits only 5 percent above the current price so the numbers look steady rather than exciting. Moderate moat and a buy-rated analyst target around 144 add little when the screen already says no.
Cyclical banking exposure plus the ethical block keep risk elevated even if earnings hold up. We see no reason to stretch the mandate here.
Screened names in the same industry · explore each on its own page.
TRADE
Where & how to trade · wherever in the world you are
BK trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
TRADER
The trader read · the latest dated commentary
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $143. Entered 2026-07-23 · Accumulation
JOURNAL
The dated journal · newest first, never edited
2026-07-23Accumulation$137.16-3.7%Entry 5
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $143.
2026-07-18Accumulation$142.39+0.0%Entry 4
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $143.
2026-07-15Accumulation$142.39+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-03Accumulation$142.39+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Accumulation$142.39Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.